Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adenocarcinoma of the Pancreas × paricalcitol × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 7 Resectable Pancreatic Carcinoma 1 Rectal Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Adenocarcinoma of the Pancreas 1 Adenocarcinoma 1

Interventions

paricalcitol 1 durvalumab 1 Radiotherapy 1 Radiosurgery 1 Gemcitabine 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02030860 2025-07-25

A Study of Neoadjuvant Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer

Abramson Cancer Center at Penn Medicine

Phase 1 Completed

Gastrointestinal

Adenocarcinoma of the Pancreas

Data powered by HemOnc (CC BY 4.0) Colophon ⚡